News & Updates
Showing Cardiology articles
Showing
Show Multimedia Only

ASCVD affects 1 in 6 adults with β-thalassaemia; etopivat shows promise
04 Aug 2026
byElvira Manzano
Atherosclerotic cardiovascular disease (ASCVD) affects a substantial proportion of adults with β-thalassaemia. It appears to be driven by conventional CV risk factors rather than disease-specific features, according to research presented at EHA2026.








